Absence of occult Hepatitis E virus infection among HIV immunosuppressed patients

Journal of Infection

Volumn 70, Issue 6, 2015, Pages 680-683

  Rivero Juarez, Antonio ^a   Martinez Dueñas, Loreto ^a   Martinez Peinado, Antonio ^a   Camacho, Angela ^a   Cifuentes, Celia ^b   Gordon, Ana ^a   Frias, Mario ^a   Torre Cisneros, Julian ^a   Pineda, Juan A ^b   Rivero, Antonio ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ANTIBODY PRODUCTION; ANTIBODY TITER; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LETTER; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PATIENT SELECTION; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SEROPREVALENCE; STATISTICAL ANALYSIS; VIRUS DETECTION; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS E VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VIROLOGY;

DNA, VIRAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS E VIRUS; HIV INFECTIONS; HUMANS;

EID: 84929131629     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.11.010     Document Type: Letter

References (8)

1. Rivero-Juarez A., Martinez-Dueñas L., Martinez-Peinado A., Camacho A., Cifuentes C., Gordon A., et al. High hepatitis E virus seroprevalence with absence of chronic infection in HIV-infected patients. J Infect 2014, http://dx.doi.org/10.1016/j.jinf.2014.10.016.
2. Chamie G., Bonacini M., Banqsberg D.R., Stapleton J.T., Hall C., Overton E.T., et al. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis 2007, 44:577-583.
3. Shire N.J., Rouster S.D., Stanford S.D., Blackard J.T., Martin C.M., Fichtenbaum C.J., et al. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr 2007, 44:309-314.
4. Jagjit Singh G.K., Ijaz S., Rockwood N., Franworth S.P., Devitt E., Atkins M., et al. Chronic hepatitis E as a cause forcryptogeniccirrhosis in HIV. J Infect 2013, 66:103-106.
5. Kenfak-Foguena A., Schöni-Affolter F., Bürgisser P., Witteck A., Darling K.E., Kovari H., et al. Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011, 17:1074-1078.
6. Bendall R., Ellis V., Ijaz S., Ali R., Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010, 82:799-805.
7. Madejón A., Vispo E., Bottecchia M., Sánchez-Carrillo M., García-Samaniego J., Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009, 16:895-896.
8. Neukam K., Barreiro P., Macías J., Avellón A., Cifuentes C., Martin-Carbonero L., et al. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis 2013, 57:465-468.